Suppr超能文献

从产紫青霉G59的新霉素抗性突变体3-f-31中分离得到的新型生物碱化合物——青霉变宁C。

Penicimutanin C, a New Alkaloidal Compound, Isolated from a Neomycin-Resistant Mutant 3-f-31of Penicillium purpurogenum G59.

作者信息

Wang Nan, Dong Yuan, Yang Yu, Xu Rui, Li Chang-Wei, Cui Cheng-Bin

机构信息

State Key Laboratory of Toxicology and Medical Countermeasures, Institute of Pharmacology and Toxicology, Beijing, 100850, P. R. China.

Integrative Medical Center, The Fifth Medical Center of PLA General Hospital, Beijing, 100039, P. R. China.

出版信息

Chem Biodivers. 2020 Jul;17(7):e2000241. doi: 10.1002/cbdv.202000241. Epub 2020 Jun 30.

Abstract

Penicimutanin C, a new alkaloidal compound, was isolated from the neomycin-resistant mutant strain 3-f-31 of the marine-derived fungus, Penicillium purpurogenum G59, together with four known compounds. The structure of penicimutanin C, including the absolute configuration, was determined by spectroscopic and chemical methods. The absolute configuration of penicimutanin A was also re-confirmed by Marfey's and chiral HPLC analyses of the hydrolyzed products. Penicimutanins C and A inhibited the proliferation of five human cancer cell lines to some extent. Penicimutanin C is the third dimer of diketopiperazine and penicimutanolone, which are only produced by mutants of P. purpurogenum G59 isolated to date, and it showed cytotoxic activity against human cancer cell lines. The neomycin-resistant screening strategy has been previously successfully used to discover new compounds by activating silent metabolites in fungi, and the present results provide an additional example of the effectiveness of this method.

摘要

从海洋来源的真菌产紫青霉G59的新霉素抗性突变株3-f-31中分离出一种新的生物碱化合物青霉突变宁C,同时还分离出四种已知化合物。通过光谱和化学方法确定了青霉突变宁C的结构,包括其绝对构型。还通过对水解产物的马尔费法和手性高效液相色谱分析重新确认了青霉突变宁A的绝对构型。青霉突变宁C和A在一定程度上抑制了五种人类癌细胞系的增殖。青霉突变宁C是二酮哌嗪和青霉突变酮醇的第三种二聚体,迄今为止仅由产紫青霉G59的突变体产生,并且它对人类癌细胞系表现出细胞毒性活性。新霉素抗性筛选策略此前已成功用于通过激活真菌中的沉默代谢产物来发现新化合物,目前的结果为该方法的有效性提供了又一个例证。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验